Advantage Medical Marijuana on the Canada Market

The legalization of marijuana has made it possible for patients to access cannabis for treatment of a variety of ailments. Patients can access medical Cannabis delivery Halifax for a variety of purposes, such as treatment of neuropathic low-back pain, HIV/AIDS, Tourette syndrome, and other conditions. The new laws also have many positive effects on society. While many of these uses are not yet fully understood, these benefits are still worth exploring.

Case studies of patients with neuropathic low-back pain

In the case studies, participants completed a questionnaire with demographics and symptom severity rating scales, an 11-point numerical symptom relief rating scale, a list of possible side effects, and a subjective measure of function. Each question took about 15 minutes to complete. The follow-up period was a mean of 23.6 months for the 27 patients. They ranged in age from 31 to 61 years old, and their pain diagnoses included neuropathic low-back pain, radiculopathy, spondyloarthritic neuropathic pain, and a number of others.

Patients with Tourette syndrome

There is no known cure for Tourette syndrome, but medical marijuana may provide some relief. While it may not be a complete cure, marijuana is known to reduce the frequency and severity of tics associated with the disorder. People with Tourette syndrome experience repeated, uncontrollable movements and sounds that can be disruptive and painful. While the cause of the disorder is unknown, genetics are believed to play a part in the onset of the disorder. It may be acquired at birth or may persist into adulthood.

Patients with dementia

A recent study examined the effects of medical marijuana on the brain and dementia. Using Halifax marijuana delivery CBD product as a treatment for dementia improved cognition and sleep, and reduced symptoms of cognitive decline. Unlike pharmaceutical drugs, which can increase the risks associated with multiple medications, cannabis is considered safe. Its adverse effects are similar to those associated with other natural substances, and are not greater than those of pharmaceutical drugs. However, physicians must take the risk of interacting multiple medications into account before prescribing cannabis for patients with dementia.

 Patients with HIV/AIDS

A recent Canadian government-sponsored trial shows that cannabis can improve appetite in HIV/AIDS patients. The study also evaluated the effects of marijuana on HIV medication, mood, pain, and neurocognitive function. Medical marijuana has also been approved by the New South Wales government for compassionate use and research purposes. In the United States, doctors aren’t so sure. While the medical marijuana is not approved for the treatment of AIDS, the researchers have been able to show promising results for patients.

Patients with multiple sclerosis

A study that started in 2006 found that cannabis-based medicine helps patients with multiple sclerosis. It involved four hundred and sixty-three patients ranging from age nine to eighty-five. Researchers compared the effect of cannabis extract on spasticity. The drug was accompanied by dronabinol, a chemically synthesized form of THC. Although it is still a controversial medicine, the study found no differences in spasticity between patients who were given the cannabis based medicine and those who had a placebo.